2019 Company Competition Pricing 
TechCrunch LA
APRIL 9, 2020
The CEO of the high-performance Italian motorcycle manufacturer offered that point of optimism, as her Modena based EV company remains closed by government decree. Before the health crisis shutdown most of Italy, Energica had already seen larger demand for its high-performance e-motos, with a price range of $17,000 to $23,000.
Both Sides of the Table
SEPTEMBER 15, 2022
<== Our conclusion was that this isn’t a temporary blip that will swiftly trend-back up in a V-shaped recovery of valuations but rather represented a new normal on how the market will price these companies somewhat permanently. We’ll just wait until companies that last raised in 2019 or 2020 come to market.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Both Sides of the Table
DECEMBER 11, 2022
I started my first company in 1999 and was admittedly swept up in all of this: Magazine covers, fancy conferences, artificial valuations and easy money. In those years I learned to properly build product, price products, sell products and serve customers. Between 2006–2008 I sold both companies that I had started and became a VC.
TechCrunch LA
MAY 20, 2021
So in 2019 she founded Eano , a San Francisco-based startup that aims to walk a homeowner through a renovation and help connect individual contractors with new clients. Eano, she said, offers competitive and transparent pricing so that homeowners aren’t surprised as a remodeling project goes on.
TechCrunch LA
DECEMBER 8, 2020
He did note that in the four markets where the company has gone live since launching its business in January 2019 — San Diego, Los Angeles, the Inland Empire , and Sacramento — has yielded an annualized revenue run rate of over $400 million in gross merchandise value (the total value of home sales transacted on its platform).
Xconomy
OCTOBER 28, 2016
THIS WEEK IN DRUG PRICING…. —A coalition of investors pressed drug makers to justify price increases. The group filed shareholder resolutions with 11 companies and cited a Kaiser Family Foundation poll that cited Americans’ concerns over drug prices. IPO’S, BIG AND SMALL. DEALS AND FUNDINGS.
Both Sides of the Table
NOVEMBER 14, 2017
An alternate outcome that I also unfortunately observe in some cases are companies who had extreme early success with an initial product adoption but failed in key areas that limited the growth and therefore the ultimate financial outcomes. I see many companies that don’t make this transition well.
Expert insights. Personalized for you.
277 
Let's personalize your content